InnoCan Pharma Corporation
INNO
Pozycja w akcjach
#33960
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Cena akcji
$1.35
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$6.08M
Zmiana (1 dzień)
-3.08%
Zmiana (1 rok)
-89.20%
Kraj
CA
Handel InnoCan Pharma Corporation (INNO)
Kategoria
Healthcare
Historia ceny akcji dla InnoCan Pharma Corporation (INNO)
Najwyższa cena zamknięcia: $1.37 dnia 2026-10-01
Najniższa cena zamknięcia: $11.93 dnia 2020-11-01
Najniższa cena zamknięcia: $11.93 dnia 2020-11-01
Historia cen akcji firmy InnoCan Pharma Corporation od 2020 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -38.79% |
| 2025 | -29.02% |
| 2024 | -47.91% |
| 2023 | 42.26% |
| 2022 | -67.12% |
| 2021 | 201.26% |
| 2020 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
